AniCura
A European network of veterinary hospitals and clinics providing primary, specialist, emergency, and referral care for companion animals.
Last updated August 31, 2026
Overview
AniCura is a European veterinary-care organization operating a network of animal hospitals and clinics focused primarily on companion animals, especially dogs and cats. The organization was established in Sweden in 2011 and grew from the idea that combining veterinary hospitals could make it easier to share clinical resources, specialist expertise, equipment, and knowledge. It was described as the first major merger of companion-animal hospitals in the Nordic region. The business combines general veterinary care with advanced and referral-level medicine. Its clinics provide preventive services, routine consultations, diagnostics, medical treatment, surgery, emergency and intensive care, rehabilitation, physiotherapy, and dietary advice. Specialist capabilities include internal medicine, surgery, orthopaedics, ophthalmology, neurology, dentistry, dermatology, endoscopy, and magnetic resonance imaging. Some hospitals also act as referral centers for surrounding practices and as training environments for veterinary professionals. AniCura expanded progressively from its Swedish base into other Nordic markets and then across continental Europe. Its stated operating footprint includes Sweden, Norway, Denmark, Germany, Austria, Switzerland, the Netherlands, Spain, Italy, France, Belgium, Portugal, Andorra, and Poland. The network comprises approximately 450 animal hospitals and clinics and is reported to serve about 3.6 million pets annually. The organization has approximately 11,000 employees, including around 4,000 veterinarians; roughly half of the workforce is reported to hold a national or international specialist qualification. Research and evidence-based practice are central parts of AniCura's professional positioning. The AniCura Scientific Council was established in 2013 to encourage research and support the use of scientific and empirical evidence in clinical work. In 2015, AniCura created the AniCura Research Foundation to fund and strengthen veterinary research and clinical development. AniCura became part of Mars Petcare in 2018 after Nordic Capital sold its holding to Mars, Incorporated. The transaction placed the veterinary network within a wider privately held group whose activities include pet nutrition and veterinary care. AniCura continues to operate as a veterinary-services brand rather than as a consumer pet-food label, with its network model allowing local hospitals and clinics to retain clinical functions while benefiting from shared infrastructure, professional standards, and specialist collaboration. The available reference material reports annual turnover of approximately SEK 5.5 billion, although the relevant reporting period is not specified.
History
AniCura was established in Sweden in 2011 with a consolidation model for companion-animal hospitals. The founding concept was that veterinary hospitals could improve care by pooling resources and collaborating across locations. This made AniCura an early Nordic example of a multi-site veterinary organization rather than a single independent practice. Its model combined local clinical operations with access to broader specialist knowledge, equipment, referral pathways, and professional development. The organization expanded first within Scandinavia. It entered Norway in 2012 and Denmark in 2013. Denmark also provided a historical connection to the broader veterinary network: AniCura Københavns Dyrehospital in Copenhagen marked its centenary in 2015, reflecting the long-established clinical traditions of some institutions that became part of the group. In 2013, AniCura created its Scientific Council. The council's role was to encourage research and help ensure that clinical methods were informed by scientific and empirical evidence. This emphasis supported AniCura's positioning as more than a collection of general veterinary practices; the organization sought to develop a professional network capable of sharing expertise and advancing clinical standards. The next phase of expansion reached Germany, Austria, and the Netherlands in 2015. In the same year, AniCura established the AniCura Research Foundation, intended to support veterinary medical research and clinical development. The foundation complemented the Scientific Council by providing a structure for funding research relevant to veterinary practice. AniCura entered Switzerland in 2016. In 2019, it expanded into Spain, France, and Italy. The available reference material also identifies operations in Belgium, Portugal, Andorra, and Poland, demonstrating the network's wider European reach. The organization developed a structure in which hospitals and clinics could provide primary care while selected sites offered advanced diagnostics, surgery, intensive care, and referral-level specialties. AniCura's medical scope includes preventive and basic veterinary care, medical and surgical treatment, emergency care, intensive care, rehabilitation, physiotherapy, and nutritional guidance. Its specialist areas include internal medicine, surgery, orthopaedics, ophthalmology, neurology, dentistry, and dermatology. Diagnostic capabilities mentioned in the reference material include endoscopy and magnetic resonance imaging. Hospitals within the network may also serve surrounding clinics by accepting referrals and by contributing to professional training. In June 2018, Nordic Capital sold its holding in AniCura to Mars, Incorporated. The transaction made AniCura part of Mars Petcare, linking the veterinary business with a broader privately owned group active in pet nutrition and veterinary care. AniCura remained a distinct veterinary-care network under that ownership. The reference material describes AniCura as operating approximately 450 hospitals and clinics across Europe, serving roughly 3.6 million pets each year. It reports approximately 11,000 employees, including about 4,000 veterinarians, with around half of employees holding some form of national or international specialist qualification. The same material reports annual turnover of approximately SEK 5.5 billion, but does not identify the applicable financial year. AniCura's head office is located in Danderyd in the Stockholm area.
- 2019Expansion into Spain, France, and Italy
AniCura establishes operations in three additional European markets.
- 2018Mars acquires AniCura
Mars, Incorporated acquires Nordic Capital's holding in AniCura, making the veterinary network part of Mars Petcare.
- 2016Expansion into Switzerland
AniCura establishes operations in Switzerland.
- 2015Central European expansion and research foundation
AniCura establishes operations in Germany, Austria, and the Netherlands and creates the AniCura Research Foundation. AniCura Københavns Dyrehospital also marks its centenary.
- 2013Expansion into Denmark and creation of the Scientific Council
AniCura enters Denmark and establishes a Scientific Council to promote research and evidence-based veterinary practice.
- 2012Expansion into Norway
AniCura establishes operations in Norway, extending its network beyond Sweden.
- 2011AniCura is established in Sweden
AniCura is created as a Nordic network model for companion-animal hospitals and clinics.
Products and positioning
A European, clinically integrated veterinary-care network combining local primary care with specialist, referral, emergency, research, and training capabilities.
Primary and preventive veterinary careVeterinary services
Routine and preventive services for companion animals, including consultations, general medical assessment, basic treatment, and ongoing health support. These services form the local-care foundation of AniCura's hospital and clinic network and can provide an entry point to specialist or referral treatment when more advanced care is required.
Specialist and referral careVeterinary services
Advanced clinical services delivered by hospitals and clinics with specialist expertise. The stated fields include internal medicine, surgery, orthopaedics, ophthalmology, neurology, dentistry, and dermatology. Network hospitals may accept referrals from surrounding practices and provide training for veterinary professionals.
Diagnostics and intensive careVeterinary diagnostics
Diagnostic and critical-care capabilities include advanced imaging such as magnetic resonance tomography, endoscopy, intensive care, and other clinical investigations. These capabilities support the diagnosis and treatment of complex conditions in dogs, cats, and other companion animals.
Surgical and emergency veterinary careVeterinary services
Medical and surgical treatment for companion animals, including emergency care and hospital-based intensive treatment. The service scope ranges from routine procedures to complex interventions performed at hospitals with appropriate equipment and specialist staff.
Rehabilitation, physiotherapy, and dietary adviceAnimal wellness services
Post-treatment and ongoing support services include rehabilitation, physiotherapy, and nutritional or dietary guidance. AniCura also offers selected animal foods and care products alongside its clinical services.
Veterinary research and clinical developmentResearch and professional development2013
Through its Scientific Council and AniCura Research Foundation, the organization supports research, evidence-based methods, and clinical development in veterinary medicine. This is an institutional capability rather than a conventional consumer product line.
Flagship businesses
- Companion-animal hospital care
- Specialist veterinary medicine
- Advanced diagnostics
- Emergency and intensive veterinary care
- Referral services for dogs, cats, and other pets
Brand decisions
- 2018Join Mars Petcare through the sale to Mars, IncorporatedM&A
Nordic Capital held an ownership position in AniCura while the veterinary network was expanding across Europe.
What changed. In June 2018, Nordic Capital sold its holding in AniCura to Mars, Incorporated. AniCura became part of Mars Petcare while continuing as a distinct veterinary-care organization.
Aftermath. The acquisition connected AniCura's European veterinary network with Mars Petcare's broader activities in veterinary care and pet nutrition. The reference material reports an approximate transaction valuation of EUR 2 billion, but does not provide a detailed financial breakdown.
Approximate transaction valuation. Approximately EUR 2 billion (2018 transaction)
Recent events
- 2019AniCura expands its European veterinary network
AniCura established operations in Spain, France, and Italy as part of its continued expansion beyond the Nordic countries and central Europe.
Other - 2018Mars, Incorporated acquires AniCura from Nordic Capital
Nordic Capital sold its holding in AniCura to Mars, Incorporated in June 2018. The transaction brought the European veterinary network into Mars Petcare, the pet-care division of the family-owned Mars group.
M&A
Sources
Cite this profile: Cite the canonical profile. /brand-wiki/anicura · Editorial policy · How profiles are compiled